Premium
Partial Sequence of MAP2 in the Region of a Shared Epitope with Alzheimer Neuronbrillary Tangles
Author(s) -
Kosik Kenneth S.,
Orecchio Lisa D.,
Bakalis Shelley,
Duffy Lawrence,
Neve Rachael L.
Publication year - 1988
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/j.1471-4159.1988.tb01079.x
Subject(s) - epitope , cyanogen bromide , microbiology and biotechnology , chemistry , tangle , complementary dna , peptide sequence , linear epitope , epitope mapping , amino acid , biology , biochemistry , antibody , genetics , gene , mathematics , pure mathematics
A 3.3‐kilobase DNA complementary to human microtubule‐associated protein 2 (MAP2) was sequenced by the dideoxy method. The 3’end terminates at an internal Eco RI site before the polyA tail. Due to the arrangement of the cDNA insert in the λX gt 11 vector, the MAP2 fragment is not fused to β‐galactosidase when expressed. The Chou Fasman algorithm for the initial 58 amino acids from the first in‐frame methionine predicts an α helix. Beyond this point, a series of turns is predicted until amino acid 160. The frequent presence of basic residues in proximity to serines or threonines is consistent with multiple phosphorylation sites. The minimum specificity determinant for Ca 2+ /calmodulin‐dependent kinase is repeated 13 times. The sequence of a region containing a MAP2 epitope that is shared with the Alzheimer neuronbrillary tangle was determined by DNase treatment of the cDNA and antibody selecting the small resultant clones in a λ gt 11 sublibrary. Likewise, a MAP2 epitope that is not shared with the neurofibrillary tangle also has been located. Both epitopes are in the projection portion of the molecule. A bovine MAP2 cyanogen bromide fragment, which contains the epitope shared with the neurofibrillary tangle, is partially insoluble under aqueous conditions, probably due to the aggregation of oppositely charged residues. Thus, rapid cleavage of MAP2 to small peptides is probably necessary in vivo to prevent the aggregation of larger cleavage fragments.